Bacterium Immune Response Production 
pharmaphorum
OCTOBER 5, 2022
Some gonorrhoea infections have become untreatable with all seven main antibiotic classes – a situation last encountered in the 1920s before the advent of effective drugs for the bacterium. At the moment most cases are treated with azithromycin, with intravenous ceftriaxone generally reserved as a last-line therapy.
XTalks
NOVEMBER 6, 2020
Symvivo’s bacTRL Gene Therapy Platform is designed and optimized to address limitations associated with typical vaccines, including the inability to accommodate large or multiple genes, lack of specificity to targeted tissue and poor control over immune response, says the company.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
NOVEMBER 10, 2020
Interim results of the trial show that all participants developed an antibody response after two doses of the COVID-19 adjuvanted vaccine candidate. Adjuvants are used to help stimulate stronger vaccine immune responses. Medicago’s candidate product is among the first plant-based vaccines being tested for COVID-19.
pharmaphorum
MAY 31, 2022
GSK is one of the pharma industry’s top vaccine producers, giving Affinivax’ shot the marketing muscle it will need to challenge Pfizer’s Prevnar 13 and Prevnar 20 products – targeting 13 and 20 pneumococcal serotypes respectively – which together brought in around $5.3 billion in sales last year.
Expert insights. Personalized for you.
98 
Let's personalize your content